May 09, 2017 - Gilead's M&A targets may be limited because of its sizable shareholder rewards program.
Mar 16, 2017 - Zacks.com featured highlights: Covanta Holding, Etsy, PTC, Incyte and Vertex Pharmaceuticals
Apr 17, 2017 - Despite a climbing market, these stocks fell. Find out why.
Apr 18, 2017 - Drugmakers get denied, Chipotle continues gains, and earnings season gets under way. Investors have remained optimistic ahead of what could be a tumultuous week.
Sep 05, 2017 - An update on bariticinib's review timeline has Wall Street rightly excited.
Sep 21, 2017 - Why small-cap biotechs Celldex Therapeutics, Idera Pharmaceuticals, and NewLink Genetics could be big winners.
Apr 21, 2017 - NewLink Genetics intriguing IDO-inhibitors could make it a target of Gilead Sciences.
Apr 20, 2017 - Nearly 90% of this biotech's sales could be at risk within the next two years.
Apr 17, 2017 - Shares of Incyte and Eli Lilly are reeling following the FDA's rejection of their once-daily rheumatoid arthritis pill.
Sep 03, 2015 - Incyte (INCY) signs an agreement with Hengrui to develop and commercialize an anti-PD-1 monoclonal antibody, SHR-1210.